We are live on ! Find out more
NHC icon

National Healthcare

109 hedge funds and large institutions have $398M invested in National Healthcare in 2017 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 48 increasing their positions, 32 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

375% more call options, than puts

Call options by funds: $5.04M | Put options by funds: $1.06M

86% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 7

50% more repeat investments, than reductions

Existing positions increased: 48 | Existing positions reduced: 32

6% more funds holding

Funds holding: 103109 (+6)

0.69% more ownership

Funds ownership: 36.65%37.34% (+0.69%)

0% more capital invested

Capital invested by funds: $397M → $398M (+$1.44M)

Holders
109
Holders Change
+6
Holders Change %
+5.83%
% of All Funds
2.72%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
13
Increased
48
Reduced
32
Closed
7
Calls
$5.04M
Puts
$1.06M
Net Calls
+$3.98M
Net Calls Change
-$2.85M

NHC Hedge Fund Activity: Q2 2017 in Review

109 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in National Healthcare (NHC) for Q2 2017, worth a combined $398M — up 0.36% from $397M a quarter earlier.

Buyers outnumbered sellers: 13 funds opened new NHC positions and 7 closed out — a net gain of 6 holders — while 48 added to existing stakes and 32 trimmed.

The largest buyer was Renaissance Technologies, adding an estimated $4.5M. The largest seller was T. Rowe Price Associates, cutting an estimated $7.46M.

  • 109 institutional investors held National Healthcare (NHC) as of Q2 2017, up from 103 in Q1 2017.
  • Funds reported $398M of National Healthcare stock for Q2 2017, up 0.36% quarter-over-quarter.
  • 13 funds opened new National Healthcare positions in Q2 2017 and 7 closed out, a net change of +6 holders.
  • The largest National Healthcare buyer in Q2 2017 was Renaissance Technologies, an estimated $4.5M added.
  • The largest National Healthcare seller in Q2 2017 was T. Rowe Price Associates, an estimated $7.46M sold.

Based on aggregated 13F filings for Q2 2017.